Jason McCarthy, Ph.D.

Senior Managing Director
Biotechnology

Jason McCarthy, Ph.D. is a Senior Managing Director covering the biotechnology industry at Maxim Group. Dr. McCarthy joined Maxim Group in July 2014. Prior to joining Maxim he received his doctoral degree in Biomedical Sciences at the Albert Einstein College of Medicine. Dr. McCarthy also holds Master’s degree in both Biomedical Research (Albert Einstein College of Medicine) and Molecular Biology (Adelphi University), as well as a B.S. in Biochemistry from Stony Brook University.

Companies Covered: Biotechnology

ABEO Abeona Therapeutics, Inc.
ACHV Achieve Life Sciences
ADIL Adial Pharmaceuticals Inc
AGRX Agile Therapeutics, Inc.
ATNM Actinium Pharmaceuticals, Inc.
ADMP Adamis Pharmaceuticals Corporation
ADMA ADMA Biologics, Inc.
ARDS Aridis Pharmaceuticals, Inc.
ARTH Arch Therapeutics
ARTL Artelo Biosciences, Inc.
ATOS Atossa Genetics Inc.
AZUR AzurRX BioPharma, Inc.
BGNE BeiGene, Ltd.
BLPH Bellerophon Therapeutics, Inc.
BNGO BioNano Genomics, Inc
BIOC Biocept, Inc.
BIOPOR BioPorto A/S
BLFS BioLife Solutions Inc
BLRX BioLine Rx, Ltd.
BLUE bluebird bio, Inc.
BCLI Brainstorm Cell Therapeutics Inc.
CERC Cerecor Inc.
CAPR Capricor Therapeutics, Inc
CHRS Coherus Biosciences
CODX Co-Diagnostics, Inc.
CFRX ContraFect Corporation
CTSO Cytosorbents Corporation
DARE Dare Bioscience, Inc.
ENTX Entera Bio
GLMD Galmed Pharmaceuticals
GILD Gilead Sciences, Inc.
HEB Hemispherx Biopharma, Inc.
HJLI Hancock Jaffe Laboratories, Inc.
IGXT IntelGenx Technologies Corp
INMB Inmune Bio Inc.
IMMP Immutep Ltd
INO Inovio Pharmaceuticals, Inc.
NTEC Intec Pharma
IDXG Interpace Diagnostics Group, Inc.
LCTX Lineage Cell Therapeutics, Inc.
MTNB Matinas Biopharma, Inc.
MDNA.TO Medicenna Therapeutics Corp.
MESO Mesoblast Limited
MBRX Moleculin Biotech, Inc.
NTRP Neurotrope, Inc.
OMER Omeros Corporation
ONTX Onconova Therapeutics, Inc.
ONCS OncoSec Medical Inc
NAVB Navidea Biopharmaceuticals, Inc.
PSTI Pluristem Therapeutics Inc.
RQE.L Reneuron Group plc
SAVA Cassava Sciences, Inc
SCYX SCYNEXIS, Inc.
SLS SELLAS Life Sciences Group Ltd.
SINT SINTX Technologies, Inc.
SNGX Soligenix, Inc.
SPHS Sophiris Bio, Inc.
TTNP Titan Pharmaceuticals, Inc.
TROV Trovagene, Inc.
VRTX Vertex Pharmaceuticals
VKTX Viking Therapeutics, Inc.
VTGN Vistagen Therapeutics, Inc.
VNRX VolitionRx Limited